Make People and Nature Healthier Through Biotechnology
Established in 2002, GenScript is a world-leading biotechnology company dedicated to providing premium-quality reagents, custom services, and innovative solutions to accelerate biomedical research, therapeutic development, and molecular diagnostics globally. With a robust reputation for excellence, reliability, and scientific innovation, GenScript serves over 200,000 researchers in more than 100 countries, supporting transformative discoveries in immunology, oncology, neuroscience, synthetic biology, vaccine development, and personalized medicine.
GenScript’s expansive and diverse product and service portfolio includes:
Gene Synthesis & Molecular Biology Services: Industry-leading custom gene synthesis services offering unparalleled accuracy, reliability, and rapid turnaround, ideal for vaccine research, genetic engineering, and synthetic biology projects. GenScript has synthesized over 100 million base pairs, supporting groundbreaking genetic and therapeutic research.
Custom Peptide Synthesis: High-quality custom peptides with extensive modification options (fluorescent labels, phosphorylation, biotinylation), widely used in antibody production, diagnostics, drug discovery, and cell signaling studies.
Protein Expression and Purification Services: Comprehensive services for recombinant protein expression in bacterial, mammalian, yeast, and insect cell systems, delivering purified, high-quality proteins tailored for structural biology, drug screening, and functional assays.
Antibody Development & Production: Expert solutions in antibody engineering, monoclonal antibody production, and customized antibody generation, featuring advanced platforms like MonoRab™ and PrecisionAb™, ensuring highly specific, validated antibodies for research, diagnostics, and therapeutics.
CRISPR Gene Editing Solutions: Innovative and reliable CRISPR reagents, sgRNA design services, and genome editing validation tools, supporting precise gene modification for therapeutic research, functional genomics, and cell-line engineering.
Therapeutic Discovery & Manufacturing: GMP-grade reagents and comprehensive CDMO services, including plasmid DNA production and therapeutic antibody development, facilitating clinical and therapeutic breakthroughs.
Headquartered in Piscataway, New Jersey, USA, GenScript operates globally through state-of-the-art manufacturing and R&D facilities located in the United States, Asia, and Europe. GenScript’s stringent quality management systems are ISO 9001 and ISO 13485 certified, providing exceptional consistency and reliability to researchers and biotechnology companies worldwide.
Committed to scientific innovation and sustainability, GenScript continues investing in cutting-edge technologies, partnerships, and sustainable practices, striving to positively impact both human health and environmental wellbeing.
Partnering with GenScript means accessing world-class biotechnology expertise, exceptional service quality, and innovative solutions, empowering you to achieve impactful discoveries and advancements in life science research and healthcare.